Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Vasudev, N.S. ORCID logo https://orcid.org/0000-0001-8470-7481
  • Ainsworth, G.
  • Brown, S.
  • Pickering, L.
  • Waddell, T.
  • Fife, K.
  • Griffiths, R.
  • Sharma, A.
  • Katona, E.
  • Howard, H.
  • Velikova, G.
  • Maraveyas, A.
  • Brown, J.
  • Pezaro, C.
  • Tuthill, M.
  • Boleti, E.
  • Bahl, A.
  • Szabados, B.
  • Banks, R.E.
  • Brown, J.
  • Venugopal, B.
  • Patel, P.
  • Jain, A.
  • Symeonides, S.N.
  • Nathan, P.
  • Collinson, F.J.
  • Powles, T.
Copyright, Publisher and Additional Information:

© 2023 by American Society of Clinical Oncology. This is an author produced version of an article published in Journal of Clinical Oncology. Uploaded in accordance with the publisher's self-archiving policy.

Dates:
  • Published (online): 6 November 2023
  • Accepted: 9 October 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
Funding Information:
Funder
Grant number
Bristol Myers Squibb
PRISM
Depositing User: Symplectic Publications
Date Deposited: 19 Oct 2023 11:18
Last Modified: 06 Nov 2024 01:21
Published Version: https://ascopubs.org/doi/full/10.1200/JCO.23.00236
Status: Published online
Publisher: American Society of Clinical Oncology
Identification Number: 10.1200/JCO.23.00236
Open Archives Initiative ID (OAI ID):

Export

Statistics